Creating and testing specialized antibodies for research purposes
Official title: PROTEOMIC AND ANTIBODY PRODUCTION AND CHARACTERIZATION
Funded at Leidos Biomedical Research, INC. · NIH-11219238 · Data updated 2026-11-12
This study is all about creating special antibodies that scientists can use for their research, making sure they are high-quality and tailored to what each researcher needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $10,719,410 |
| NIH project number | 75N91019D00024-0-759102400029-1 |
| Project ID | NIH-11219238 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and laboratories in need of specialized antibodies for their scientific studies.
✕Less likely to help
Patients who are not involved in scientific research or do not require specific antibodies for their work may not receive any benefit from this research.
What this research studies
This research focuses on producing and characterizing specific antibodies tailored to meet the needs of individual researchers. By utilizing validated methods, the project aims to ensure high-quality and reproducible affinity reagents that can be used in various scientific applications. The research will involve a cycle of target requests, where antibodies will be developed based on the specifications provided, with a focus on both traditional mouse monoclonal antibodies and rabbit monoclonal antibodies depending on the target type. This approach aims to enhance the availability of reliable tools for the scientific community.
Why it matters
Potential benefit: If successful, this research could provide researchers with high-quality, customized antibodies that improve the accuracy and reliability of scientific experiments.
How similar studies have gone: Previous research has shown success in producing specialized antibodies, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.